Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries.
about
Alternative methods of diagnosing drug resistance--what can they do for me?Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationCost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in ChinaEmerging technologies for monitoring drug-resistant tuberculosis at the point-of-careClinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosisTargeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005-2008.Implementation of HIV and Tuberculosis Diagnostics: The Importance of Context.TB diagnostic tests: how do we figure out their costs?Mathematical models of the epidemiology and control of drug-resistant TB.Drug-resistant tuberculosis: an insurmountable epidemic?A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate.An econometric method for estimating population parameters from non-random samples: An application to clinical case finding.Susceptibility of Mycobacterium tuberculosis to first-line antimycobacterial agents in a Brazilian hospital: assessing the utility of the tetrazolium (MTT) microplate assay.Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India.Microbial sensor for drug susceptibility testing of Mycobacterium tuberculosis.
P2860
Q26852644-E41F707E-5911-43C9-90EC-C9CCDA323B2BQ28477855-8CE21C1E-E7D8-4D1B-82BC-D79196D409DBQ28485280-602ACBE8-3E8F-4F52-9544-38EC3E5DC91FQ28534773-994EBB6C-EFFC-4C05-829E-4585F258EEA7Q30397647-3A016873-4021-49A1-8568-88B661B3C664Q33658873-449C882D-7632-4EE4-901B-949E30ECEF86Q34395434-005F55DF-DCC1-4636-8B0D-E2C5FFD574D9Q35129505-2CB9E8B4-C830-43E4-9806-668252D1E5BFQ35193563-D2778DF7-A1D9-44FE-85E9-3A907DE2D19FQ36094194-E966D2DF-9109-49DC-82B2-1A266FE14AD4Q37579924-F9BC34CD-7CD2-4373-972E-252003C68438Q37754966-D246FC82-9E52-4F79-B978-465322D31ED8Q37815427-82E1A2EF-E23E-498B-A532-3F888D5B5411Q38088848-DB284EE8-22E3-4F44-ABFC-8F71BF110F90Q38604010-22E60C60-0979-4106-AACF-ACA7809F8332Q42909605-F454EBFD-38BE-43AF-8879-F515CDB406C1Q46200901-A48BDA67-0AE8-4579-B859-3162973FED90Q47605240-A132B91A-DACB-4C96-932F-D8DF6DC44E2D
P2860
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cost-effectiveness analysis of ...... is in middle-income countries.
@en
type
label
Cost-effectiveness analysis of ...... is in middle-income countries.
@en
prefLabel
Cost-effectiveness analysis of ...... is in middle-income countries.
@en
P2093
P2860
P356
P1476
Cost-effectiveness analysis of ...... is in middle-income countries.
@en
P2093
Carlos Acuna-Villaorduna
Carlos Seas
Eduardo Gotuzzo
German Henostroza
Humberto Guerra
Jane Cunningham
Juan Saravia
Lucy Vasquez
Luis Llanos-Zavalaga
Mark D Perkins
P2860
P304
P356
10.1086/590010
P407
P50
P577
2008-08-01T00:00:00Z